The development and evaluation of a tublysine-based antibody-drug conjugate with enhanced tumor therapeutic efficacy
Antibody-drug conjugates (ADCs) offer targeted cancer therapy by delivering cytotoxic agents directly to tumor cells. However, challenges such as relapse, resistance, and diverse patient needs drive ongoing innovation in ADC development. Exploration of new small-molecule toxins with unique antitumor...
Saved in:
Main Authors: | Huihui Guo, Hongsheng Xie, Yuanyuan Huang, Junxiang Jia, Xiangfei Kong, Qingliang Yang, Shun Gai, Wenjun Li, Lu Bai, Lingli Zhang, Xiaoxiao Chen, Zhicang Ye, Hangbo Ye, Linyao Zhao, Yifang Xu, Yong Du, Xiuzhen Zhang, Miaomiao Chen, Xiaomai Zhou, Robert Y. Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1532104/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PCR-based detection of Botryosphaeria canker pathogens in fig trees
by: Mahdiyeh Ghaedi, et al.
Published: (2025-02-01) -
Current issues with antibody-conjugated lipid nanoparticles
by: Aayush
Published: (2025-02-01) -
AN EXAMINATION OF CONJUGATIONAL SUFFIXES OF PASSIVE CONSTRUCTIONS IN FULFULDE
by: YAHAYA MOHAMMED AHMED
Published: (2024-07-01) -
Adaptive backstepping control for electro-hydraulic servo system in extension sleeve press-fitting process of bearing pressing machine
by: Chen Hongsheng
Published: (2025-01-01) -
Hybrid azole-based conjugates as upcoming anticancer and antimicrobial agents
by: Luís M. T. Frija, et al.
Published: (2023-11-01)